Modelwire
Subscribe

Researcher deploys ChatGPT and Codex to identify antimicrobial drug candidates

Illustration accompanying: How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules

Researchers are leveraging large language models and code generation tools to accelerate drug discovery against antimicrobial resistance, a critical public health challenge. By applying Codex and ChatGPT to mine genomic databases for novel antimicrobial compounds, de la Fuente's lab demonstrates a concrete use case where LLMs move beyond text generation into scientific hypothesis generation and molecular candidate screening. This signals a broader shift in how AI infrastructure is being repurposed for biotech workflows, potentially shortening timelines for identifying treatments to drug-resistant infections.

Modelwire context

Explainer

The key detail the summary skips is the specific workflow: Codex isn't generating drug candidates directly, it's writing the code that queries and filters genomic databases, meaning the LLM is acting as a lab automation layer rather than a chemistry oracle. That distinction matters for understanding both the reliability ceiling and the reproducibility of results.

Recent OpenAI coverage on Modelwire has focused heavily on consumer and accessibility use cases, including the Manning brothers story from September 10 showing ChatGPT as an independence tool for blind users, and the ATV Big Air Tour case study showing a two-person team absorbing enterprise-scale workloads. De la Fuente's lab represents a third pattern: domain experts using general-purpose models as research infrastructure rather than as assistants. The common thread across all three is that the productivity gains come from workflow integration, not from the model doing something fundamentally new. In the scientific context, though, the stakes for errors are categorically different than in event logistics or navigation.

Watch whether de la Fuente's lab publishes peer-reviewed validation of candidates identified through this pipeline within the next 12 months. Preprint-to-publication conversion rate will be the real signal of whether LLM-assisted screening holds up under experimental scrutiny.

This analysis is generated by Modelwire’s editorial layer from our archive and the summary above. It is not a substitute for the original reporting. How we write it.

MentionsOpenAI · ChatGPT · Codex · César de la Fuente

MW

Modelwire Editorial

This synthesis and analysis was prepared by the Modelwire editorial team. We use advanced language models to read, ground, and connect the day’s most significant AI developments, providing original strategic context that helps practitioners and leaders stay ahead of the frontier.

Modelwire summarizes, we don’t republish. OpenAI originally reported this story as How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules”. The full content lives on openai.com. If you’re a publisher and want a different summarization policy for your work, see our takedown page.

Researcher deploys ChatGPT and Codex to identify antimicrobial drug candidates · Modelwire